跳至主要内容
临床试验/NCT05213988
NCT05213988Enrolling By Invitation不适用

Effects on GLUcose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic STrategies Against Diabetes-Related Metabolic Diseases

Azienda Ospedaliero, Universitaria Pisana1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年7月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
50
试验地点
1
主要终点
Glucose tolerance

研究概览

简要总结

The investigators aim to examine the impact of changes in plasma lipoproteins induced by nutritional and pharmacological interventions on glucose homeostasis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-65 years
  • both males and females

排除标准

  • acute or chronic conditions influencing glucose and lipid metabolism
  • pregnancy

研究组 & 干预措施

Low-Carbohydrate/High-Protein Diet

Experimental

干预措施: Low-Carbohydrate/High-Protein diet (Dietary Supplement)

Fibrate

Experimental

干预措施: Fibrates (Drug)

Intermittent Fasting

Experimental

干预措施: Intermittent Fasting (Dietary Supplement)

结局指标

主要结局

Glucose tolerance

时间窗: 180 minutes

Glucose tolerance will be measured as the area under the curve of plasma glucose levels in response to a 180-minute 75g oral glucose tolerance test (OGTT)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Natali

Full Professor

Azienda Ospedaliero, Universitaria Pisana

研究点 (1)

Loading locations...

相似试验